Atlas Venture Associates Ix, LLC / NTLA
Atlas Venture Associates Ix, LLC’s Intellia Therapeutics Inc Position
Does Atlas Venture Associates Ix, LLC own Intellia Therapeutics Inc (NTLA)? Yes — 10.0K shares worth $316,200 (+2.69% of its 13F portfolio) as of Q3 2023.
Position Value
$316,200
Q3 2023
Shares
10.0K
% of Portfolio
+2.69%
Quarters Held
20
currently held
Position History NTLA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2023 | 10.0K | $316,200 | +2.69% |
| Q2 2023 | 10.0K | $407,800 | +2.23% |
| Q1 2023 | 10.0K | $372,700 | +1.75% |
| Q4 2022 | 10.0K | $348,900 | +1.74% |
| Q3 2022 | 10.0K | $560,000 | +1.66% |
| Q2 2022 | 10.0K | $518,000 | +1.18% |
| Q1 2022 | 10.0K | $727,000 | +0.67% |
| Q4 2021 | 10.0K | $1M | +0.52% |
| Q3 2021 | 10.0K | $1M | +0.45% |
| Q2 2021 | 10.0K | $2M | +0.28% |
| Q1 2021 | 1.11M | $89M | +15.01% |
| Q4 2020 | 1.62M | $88M | +13.93% |
| Q3 2020 | 1.62M | $32M | +33.22% |
| Q2 2020 | 1.62M | $34M | +36.31% |
| Q1 2020 | 1.62M | $20M | +41.77% |
| Q4 2019 | 1.62M | $24M | +41.29% |
| Q3 2019 | 1.62M | $22M | +35.49% |
| Q2 2019 | 1.62M | $26M | +28.28% |
| Q1 2019 | 1.62M | $28M | +25.92% |
| Q4 2018 | 1.62M | $22M | +25.39% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atlas Venture Associates Ix, LLC’s full portfolio or all institutional holders of NTLA.